clarithromycin has been researched along with Liver Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, W; Jiang, Q; Xu, R | 1 |
| Alù, M; Balli, F; Bertoli, G; Casolari, C; Fabio, G; Fabio, R; Gennari, W; Guaraldi, N; Migaldi, M; Nanni, N; Pecorari, M; Portolani, M; Sabbatini, AM; Tagliazucchi, S | 1 |
| Chu, SY; Decourt, JP; Fourtillan, JB; Girault, J; Granneman, GR; Pichotta, PJ | 1 |
| Rodvold, KA | 1 |
1 review(s) available for clarithromycin and Liver Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Humans; Kidney Diseases; Liver Diseases | 1999 |
3 other study(ies) available for clarithromycin and Liver Diseases
| Article | Year |
|---|---|
Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Computer Simulation; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Factor Xa Inhibitors; Humans; Ketoconazole; Liver Diseases; Male; Models, Biological; Renal Insufficiency; Ritonavir; Rivaroxaban | 2018 |
Unusual concurrent detection by polymerase chain reaction of Bartonella henselae and parvovirus b19 in an immunocompetent child with erythema nodosum and hepatic granulomatous disease.
Topics: Anti-Bacterial Agents; Bartonella henselae; Bartonella Infections; Child, Preschool; Clarithromycin; Erythema Nodosum; Female; Granuloma; Humans; Immunocompetence; Liver Diseases; Parvoviridae Infections; Parvovirus B19, Human; Polymerase Chain Reaction | 2007 |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics.
Topics: Chromatography, High Pressure Liquid; Clarithromycin; Half-Life; Humans; Liver Diseases; Metabolic Clearance Rate; Middle Aged | 1993 |